Texas Permanent School Fund Corp lowered its holdings in Ingevity Co. (NYSE:NGVT – Free Report) by 14.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 25,219 shares of the company’s stock after selling 4,174 shares during the quarter. Texas Permanent School Fund Corp owned 0.07% of Ingevity worth $1,102,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds have also recently modified their holdings of the business. Choreo LLC purchased a new position in shares of Ingevity in the second quarter worth $474,000. Isthmus Partners LLC purchased a new stake in Ingevity during the second quarter valued at $35,000. Los Angeles Capital Management LLC purchased a new stake in Ingevity during the second quarter valued at $351,000. Wakefield Asset Management LLLP purchased a new stake in Ingevity during the second quarter valued at $748,000. Finally, Victory Capital Management Inc. increased its position in Ingevity by 1.4% during the second quarter. Victory Capital Management Inc. now owns 1,028,685 shares of the company’s stock valued at $44,964,000 after acquiring an additional 13,771 shares during the last quarter. Hedge funds and other institutional investors own 91.59% of the company’s stock.
Ingevity Stock Performance
Shares of NGVT opened at $40.04 on Friday. The company has a quick ratio of 1.07, a current ratio of 1.92 and a debt-to-equity ratio of 4.92. The business has a 50-day simple moving average of $39.40 and a two-hundred day simple moving average of $44.49. The stock has a market cap of $1.45 billion, a price-to-earnings ratio of -12.87 and a beta of 1.62. Ingevity Co. has a 52 week low of $32.21 and a 52 week high of $56.29.
Wall Street Analyst Weigh In
A number of research firms recently commented on NGVT. BMO Capital Markets reduced their price objective on Ingevity from $45.00 to $42.00 and set a “market perform” rating for the company in a research report on Monday, August 5th. Oppenheimer reduced their price objective on Ingevity from $58.00 to $50.00 and set an “outperform” rating for the company in a research report on Thursday, August 1st. CJS Securities upgraded Ingevity from a “market perform” rating to an “outperform” rating and set a $58.00 price objective for the company in a research report on Wednesday, August 7th. Finally, Wells Fargo & Company reduced their price objective on Ingevity from $45.00 to $40.00 and set an “equal weight” rating for the company in a research report on Monday, August 5th. Four analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $51.33.
Read Our Latest Research Report on Ingevity
Ingevity Profile
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.
See Also
- Five stocks we like better than Ingevity
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- How Can Investors Benefit From After-Hours Trading
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- Market Cap Calculator: How to Calculate Market Cap
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Co. (NYSE:NGVT – Free Report).
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.